Abstract
A prospective survey involving 544 searches of the US National Marrow Donor Program (NMDP) Registry was conducted to identify reasons why many patients who have apparent HLA-matched donors do not proceed to transplant. Coordinators at NMDP transplant centers, patients and referring physicians were surveyed shortly after the initial search, and follow-up surveys were sent to the coordinators as the search was ongoing. The death of the patient, worsening of the patient's medical condition and length of the search process were the most commonly cited barriers to transplantation. Other times a decision was made not to transplant through the NMDP due to the use of a donor from another source, a preference for chemotherapy or immunotherapy, hesitancy on the part of the transplant physician or patient, or because the patient did not require a transplant. Responses differed between U.S. and international cases. An unrelated donor outside the NMDP was the most common reason cited by international coordinators (46%), whereas the death of the patient was the most common reason among US coordinators (13%). The death of the patient was the second most common reason cited by international coordinators at 9%. Financial problems were listed by 41% of US coordinators as a potential barrier at the time of initial search, but only 5% indicated this as an actual barrier on a follow-up survey. Finances were cited as the most important reason 3% of the time overall, and 6% for African Americans and Asian/Pacific Islanders. Bone Marrow Transplantation (2001) 27, 581–587.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hansen JA, Clift RA, Thomas ED et al. Transplantation of marrow from an unrelated donor to a patient with acute leukemia New Engl J Med 1980 303: 1311–1318
Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies Transplantation 1991 51: 443–447
Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplants from unrelated donors facilitated by the National Marrow Donor Program New Engl J Med 1993 328: 593–602
McCullough J, Hansen J, Perkins H et al. The National Marrow Donor Program: how it works, accomplishments to date Oncology 1989 3: 63–72
Zumwalt Admiral ER, Howe CWS . The origins and development of the National Marrow Donor Program Leukemia 1993 7: 1122
National Marrow Donor Program Standards Committee . Standards of the National Marrow Donor Program Transfus Med Rev 1993 33: 172–180
Perkins HA, Hansen JA . The US National Marrow Donor Program Am J Ped Hematol Oncol 1994 16: 30–34
Beatty P, Mori M, Milford E . Impact of racial genetic polymorphism upon the probability of finding an HLA-matched donor Transplantation 1995 60: 778–783
Switzer GE, Dew MA, Stukas AA et al. Factors associated with attrition from a national bone marrow registry Bone Marrow Transplant 1999 24: 313–319
Howe CWS, Radde-Stepaniak T . Hematopoietic cell donor registries. In: Forman SJ, Thomas ED, Blume KG (eds) Hematopoietic Cell Transplantation Blackwell Science: Malden, MA 1998 pp 503–512
Welte K . Matched unrelated transplants Sem Onc Nur 1994 10: 20–27
Beatty PG, Kollman C, Howe CWS . Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program. In: Cecka M and Terasaki PI (eds) Clinical Transplants 1995 UCLA Tissue Typing Laboratory: Los Angeles 1995 pp 271–277
Petersdorf EW, Smith AG, Mickelson EM et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation Blood 1993 82: 667–681
Petersdorf EW, Longton GM, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation Blood 1995 86: 1606–1613
Petersdorf EW, Longton GM, Anasetti C et al. Definition of HLA-DQ as a transplantation antigen Proc Natl Acad Sci USA 1996 93: 15358–15363
Petersdorf EW, Longton GM, Anasetti C et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors Blood 1997 89: 1818–1823
Acknowledgements
We would like to extend our appreciation to the NMDP transplant center coordinators and referring physicians who took the time and effort to complete the surveys for this study. We especially want to thank the patients and their families for their willingness to share a part of their experience during a time of deep personal crisis in the hope of helping others. We are also grateful to Nancy Morgan for her assistance in the preparation of this manuscript. This work was supported by the National Marrow Donor Program in part through funding from the Health Resources and Services Administration (Contract No. 240–97–0036) and the Office of Naval Research (Cooperative Agreement Nos N00014–96–2–0016 and N00014–99–2–0006). The views expressed in this article do not reflect the official policy or position of the Department of the Navy, the Department of Defense, or the US government.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kollman, C., Weis, T., Switzer, G. et al. Non-HLA barriers to unrelated donor stem cell transplantation. Bone Marrow Transplant 27, 581–587 (2001). https://doi.org/10.1038/sj.bmt.1702845
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702845
Keywords
This article is cited by
-
Motives for joining an unrelated HSC donor registry: description, categorization, and association with donor availability
Bone Marrow Transplantation (2019)
-
Racial disparities in hematopoietic cell transplantation in the United States
Bone Marrow Transplantation (2012)
-
Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group
Bone Marrow Transplantation (2012)
-
Criteria for initiation and evaluation of minority donor programs and application to the example of donors of Turkish descent in Germany
Bone Marrow Transplantation (2009)
-
The importance of identifying a back-up donor for unrelated stem cell transplantation
Bone Marrow Transplantation (2005)